The Vanguard Group's Position in Spire Healthcare Group

The Vanguard Group, Inc. has disclosed its position regarding Spire Healthcare Group plc in compliance with Rule 8.3 of the Takeover Code. As of September 11, 2026, Vanguard holds significant interests in Spire, owning 14,404,778 ordinary shares, which account for 3.58% of the relevant securities. No rights to subscribe for new securities are reported. The disclosure reveals a recent sale of 4,436 shares at a price of 2.46 GBP per share.

There are no agreements, indemnities, or understandings related to options or derivatives associated with the securities. No Supplemental Form 8 was attached, indicating no open derivative positions requiring disclosure. This disclosure maintains transparency in The Vanguard Group's holdings in Spire Healthcare, crucial for stakeholders amidst potential takeover considerations.